Project Details
Description
A Phase 1 open-label, single ascending dose study of ABA-201 in participants with new onset type 1 diabetes (Stage 3)
Status | Active |
---|---|
Effective start/end date | 10/22/24 → 10/20/35 |
Funding
- ABATA THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.